title: Enterovirus infections following T-cell depleted allogeneic transplants in adults.
abstract: Anecdotally, enteroviruses have been reported to cause serious complications post BMT, but the exact impact of these viruses in the post transplant period has not been reported. We prospectively evaluated stool, urine and throat samples for enteroviruses by viral culture together with relevant body fluids by RT-PCR in 64 allograft recipients receiving grafts T-cell depleted by Campath-1H, following both conventional and reduced-intensity conditioning. Seven patients (10.4%) developed nine episodes of enterovirus infections at a median of 146 days post transplant. Four episodes were associated with symptomatic illnesses, which could be attributable to enteroviruses. There was no mortality directly related to enteroviruses. There was no correlation between dose and mode of Campath-1H use, lymphocyte recovery, IgG and IgA levels and enterovirus isolation. Although enteroviruses tended to be more frequent in TBI-based conventional conditioning recipients, the only significant risk factor for enterovirus infection was unrelated donor graft. The low incidence of the severe enterovirus infections could have been related to a low lymphocyte count in this cohort in the absence of GVHD, particularly CD4+ count, which has been implicated in tissue damage in experimental animals. Further studies are needed to define its impact in different allograft settings.
authors.affiliation: Departments of Haematology, Birmingham Heartlands Hospital, Birmingham, UK. suparno@doctors.org.uk
authors.forename: S
authors.initials: S
authors.lastname: Chakrabarti
authors.forename: H
authors.initials: H
authors.lastname: Osman
authors.forename: K E
authors.initials: KE
authors.lastname: Collingham
authors.forename: C D
authors.initials: CD
authors.lastname: Fegan
authors.forename: D W
authors.initials: DW
authors.lastname: Milligan
mesh_terms: D000293:Adolescent; D000328:Adult; D004770:Enterovirus / Q000302:isolation & purification; D004769:Enterovirus Infections / Q000209:etiology* / Q000401:mortality / Q000821:virology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D007107:Immune System / Q000502:physiology; D015994:Incidence; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000209:etiology / Q000401:mortality / Q000821:virology; D011336:Probability; D011446:Prospective Studies; D012038:Regeneration; D012307:Risk Factors; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods; D014184:Transplantation, Homologous